Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Evolent Health Convertible Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Evolent Health, Inc. of $125 million…
Teleflex Acquires Vascular Solutions
Davis Polk is advising JP Morgan as financial adviser to Teleflex Incorporated in connection with its approximately $1…
Davis Polk Advises Roche on Its Sale of Florence, South Carolina, Manufacturing Site to Patheon
Davis Polk is advising Roche Holding Ltd. in connection with the sale of an active pharmaceutical ingredients manufacturing…
Abbott Laboratories $15.1 Billion Notes Offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Abbott Laboratories of $2.85 billion…
AbbVie Inc. €3.6 Billion Senior Notes Offering
Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by AbbVie Inc. of …
Merck €1 Billion Notes Offering
Davis Polk advised the representatives of the underwriters, in connection with the offering of €1 billion aggregate…
Theravance Biopharma, Inc. Concurrent Ordinary Shares and Convertible Senior Notes Offerings
Davis Polk advised the joint book-running managers in connection with a $100.1 million SEC-registered offering of 3,850…
Davis Polk Advises Roche Holdings on Its $1.5 Billion Notes Offering
Davis Polk advised Roche Holdings, Inc. in connection with its Rule 144A/Regulation S offering of $650 million aggregate…
iRhythm Technologies, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the initial public…
Davis Polk Advises Advanced Accelerator Applications S.A. on Its Follow-On Offering
Davis Polk advised Advanced Accelerator Applications S.A. on its approximately $150 million SEC-registered follow-on…